Surgical treatment of the ischemic heart disease with severe left ventricular systolic dysfunction

O.V. Zelenchuk, B.M. Todurov

References

1. Belenkov YuN, Ageev FT, Mareev VYu. Paradoxes of heart failure. Russian Heart Failure Journal. 2000;1:4. (in Russ.).
2. Belenkov YuN. Chronic heart failure in Russia. Russian Heart Failure Journal. 2003;4(1):9-11. (in Russ.).
3. Bokeria LA, Buziashvili YuI, Kliuchnikova IV. Ischemic remodeling of the left ventricle. Мoskva, 2002. (in Russ.).
4. Ioseliani DG Ischemic heart disease in the aspect of surgical treatment. Мoskva, 1979. (in Russ.).
5. Kertzman VP, Vasilkova LS, Gigilashvili KN CABG in patients with IHD with a low fraction of left ventricular ejection of the heart. Actual problems of cardiovascular surgery. Vilnius, 1986:183-185. (in Russ.).
6. Kertzman VP. Acute heart failure after surgery in conditions of artificial circulation. Мoskva, 1989. (in Russ.).
7. Mikheev AA, Klyuzhev VM, Karpun NA Coronary artery surgery. Мoskva: Medpraktika-М, 2001. 80 с. (in Russ.).
8. Samoylenko LE. Perfusion scintigraphy of myocardium in clinical cardiology. Мoskva, 1995. (in Russ.).
9. Skridlevskaya EA. Treatment of patients with coronary artery disease with postinfarction left ventricular aneurysms. Мoskva, 1995. (in Russ.).
10. Chinaliev SK Aortocoronary bypass in patients with ischemic heart disease. Мoskva, 1995. (in Russ.).
11. Chernyavsky AM, Marchenko AV, Khapaev SA. Reconstructive surgery of postinfarction left aneurysms of the heart. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2000;1-2:30-35. (in Russ.).
12. Chernyavsky AM, Karaskov AM, Marchenko AV, Hapaev SA. Reconstructive surgery of postinfarction left ventricular aneurysms. Novosibirsk, 2003. 179 с. (in Russ.).
13. Shiriaev AA. Effectiveness of microsurgical myocardial revascularization. Мoskva, 1994. (in Russ.).
14. АСС/АНА Guidelines for Coronary Artery Bypass Graft Surgery. JACC. 1999;34(4):1262-1347.
15. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983. N 68:785-795.
16. Alfieri O. Coronary artery bypass grafting for left ventricular dysfunction. J Curr Opin Cardiol. 1994;9(6):658-663.
17. Anversa P, Sonnenblick EH. Ischemic cardiomyopathy: pathophysiologic mechanisms. J Prog Cardiovasc Dis. 1990;23(1):49-70.
18. Anversa P, Kajstura J, Reiss K, et al. Ischemic cardiomyopathy: myocyte cell loss, myocyte cellular hypertrophy, and myocyte cellular hyperplasia. J Ann NY Acad Sci. 1995;752:47-64.
19. Anversa P, Loud A.V. Absolute morphometric study of myocardial hypertrophy in experiment. J Lab Invest. 1978;38:597-609.
20. Arbogazt R, Solignac A, Bourassa M.G. Influence of aortocoronary saphenous vein bypass, surgery in left ventricular volumes and ejection fraction: Comparison beforeand one year after surgery in 51 patients. Amer J Med. 1973;54:290-296.
21. Arom KV, Flavin TF, Emery RW, et al. Is low ejection fraction safe for off-pump coronary bypass operations? Ann Thorac Surg. 2000;70:1021-1025.
22. Baker DW, Jones R, Hodges J, et al. Management of heart failure, III: the role of revascularization on the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 1994;272:1528-1534.
23. Baumgartner FJ, Omari BO, Goldberg S, et al. Coronary artery bypass grafting in patients with profound ventricular dysfunction. Tex Heart Inst J. 1998;25:125-129.
24. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol. 1999;34:163-169.
25. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
26. Burch GE, Giles TD, Colcolough HL, et al. Ischemic cardiomyopathy. Amer. Heart. J. 1970;79:291-292.
27. Buxton DB. Dysfunction in collateral-depended myocardium: hibernation or repetive stunning? Circulaton. 1993;87(5):1756-1758.
28. Carr JA, Haithcock BE, Paone G, et al. Long-term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction. Ann Thorac Surg. 2002;74:1531-1536.
29. Castella MS. Buckberg GD, Tan Z. Blood cardioplegic protection in profoundly damaged hearts: role of Na+ - Н+ exchange inhibition during pretreatment or during controlled reperfusion supplementation. Ann Thorac Surg. 2003;75:1238-1245.
30. Christakis G, Weisel R, Fremes S, et al. Coronary artery bypass grafting in patients with poor ventricular function. J Thorac Cardiovasc Surg. 1992;103:1083-1092.
31. Cowie MR, Mosterd DA, Wood DA, et al. The epidemiology of heart failure. Eur Heart J. 1997;18:208-215.
32. Detection and clinical relevance. Kluwer Academic Publishers. 1994:1-197.
33. Dreyfus GD, Duboc D, Blasco A, et al. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg. 1994;57:1402-1408.
34. Emond M, Mock MB, Davis KB, et al. Long-term survival of medical treated patients in the coronary artery surgery study (CASS) registry. Circulation. 1994;90(6):2646-2657.
35. Evans RW, Manninen DL, Garrison LP, Maier AM. Donor availability is the determinant of the future of heart transplantation. JAMA. 1986;255:1892-1836.
36. Ferrari R, La Canno G, Giubbini R, et al. Hibernating myocardium in patients with coronary artery disease: identification and clinical importance. Cardiovasc Drugs Ther. 1992;6:287-2937.
37. Fowie MR, Mosterd DA, Grobbee DE. The epidemiology of heart failure. Eur Heart J. 1997;18:208-225.
38. Freeman AP, Walsh WF, Giles RW, et al. Early and long-term results of coronary artery bypass grafting with severely depressed left ventricular performance. Ibid. 1984;54:749-754.
39. Gimelli A, Neto J, Marcassa С et al. Beneficial effects of coronary revascularization in patients with ischemic left ventricular dysfunction with and without anginal symptoms. Interactive Cardiovascular and Thoracic Surgery. 2002;1:9-15.
40. Goldstein D.J, Beauford R.B, Luk В.et al. Multivessel off-pump revascularization in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg. 2003;24:72-80.
41. Hanch C. Total artificial heart alternative to heart transplantation. J Heart Surge. 1993;3:15-23.
42. Hausmann H, Meyer R, Siniawski H, et al. Factors excercising an influence on recovery of hibernating myocardium after coronary artery bypass grafting. Eur J Cardiothorac Surg. 2004;26:89-95.
43. Johnson MR, Costanzo-Nordin MR, Heroux AL, et al. High-risk cardiac operation; A viable alternative to heart transplantation. Ibid. 1993;55:857-882.
44. Kaul ТК, Agnihorti AK, Fields BL, et al. Coronary artery bybass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg. 1996;111:1001-1012.
45. Kennedy JW, Kaiser GC, Fisher LD, et al. Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). Circulation. 1991;63:793-802.
46. Kron IL, Flanagan TL, Blackbourne LH, et al. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg. 1989;210:348-354.
47. Lorusso R, La Carina G, Ceconi C, et al. Long-term results of coronary artery bypass grafting procedure in the presence of left ventricular dysfunction andhibernating myocardium. Eur J Cadio-Thorac Surg. 2001;20(5):937-947.
48. Louie H, Laks H, Milgalter E, et al. Ischemic cardiomyopathy: criteria for coronary revascularization and cardiac transplantation. Circulation. 1991;84 (Suppl. III):290-295.
49. Luchi R, Scott S, Deupree R, et al. Comparison of medical and surgical treatment for unstable angina pectoris: results of a Veterans Administration Cooperative Study. New Engl J Med. 1987;316:977-984.
50. Luciani GB, Faggian G, Razzolini R, et al. Severe ischemic left ventricular failure: coronary operation or heart transplantation? Ann Thorac Surg. 1993;55:719-723.
51. Mehrawal ZS, Trehan N. Off-pump coronary artery bypass grafting in patients with left ventricular dysfunction. Heart Surgery Forum. 2002;5(1):41-45.
52. Oberman A, Kouchokos K. Perioperative myocardial infarction after coronary bypass surgery. Clevel Clin Quarr. 1978;45:171-174.
53. O’Connor СМ, Velazquez EJ, Gardner LH.et al. Comparison of coronary artery bybass grafting versus medical therapy on long-term outcome in patients with ischemic cardtomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol. 2002;90:101-107.
54. Oldham HN, Kong I, Bartel AG, et al. Risk factors in coronary artery bypass surgery. Arch Surg. 1972;86:525.
55. Paluszkiewicz L, Kwinecki P, Jemielity M, et al. Myocardial perfusion correlates with improvement of systolic function of the left ventricle after CABG. Dobutamine echocardiography and Tc-99m-MIBI SPECT study. Eur J Cardiothorac Surg. 2002;21:32-35.
56. Rahimtoola SH. Coronary bypass surgery for unstable angina. Circulation. 1984;69:842-852.
57. Rahimoda SH. The hibernating myocardium. Amer Heart J. 1989;117(1):211-221.
58. Rosamond W, Flegal K, Friday G, et al. Heart Disease and Stroke Statistics-2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(5):169-171.
59. Rutherford JD, Braunwald E, Cohn PE. Chronic ischemic heart disease. Heart Disease: A Textbook of Cardiovascular Medicine / Ed. by Braunwald E. Philadelphia: Saunders, 1988:1364.
60. Salmasi AM, Salmasi S, Nicolaides A, et al. J Cardiovasc Surg. 1988;29:89-95.
61. Shah PJ, Hare DL, Raman JS, et al. Survival after myocardial revascularization for ischemic cardiomyopathy: A prospective ten-year follow-up study. J Thorac Cardiovasc Surg. 2003;126:1320-1327.
62. Shennib H, Endo M, Benhamed O, Morin JF. Surgical revascularization in patients with poor left ventricular function: on- or off-pump? Ann Thorac Surg. 2002;74:1344-1347.
63. Schinkel A, Poldermans D, Rizello V, et al. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? J Thorac Cardiovasc Surg. 2004;127:385-390.
64. Schinkel A, Bax JJ, Boersma E, et al. How many patients with ischemic cardiomyopathy exhibit viable myocardium? Am J Cardiol. 2001;88:561-564.
65. Schinkel A, Bax JJ, Geleijnse ML, et al. Noninvasive evaluation of ischemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J. 2003;24:789-800.
66. Shabettai R. Ischemic cardiomyopaty: how far have we come in 25 years, how far yet to go? J Amer Coll Cardiol. 1983;1:252-263.
67. Soliman Hamad MA, Tan ME, et al. Long-term results of coronary artery bypass grafting in patients with left ventricular dysfunction. Ann Thorac Surg. 2008;85:488-793.
68. Spenser FS, Green GE, Tice PA. Coronary artery bypass grafts in patients with congestive heart failure. A report of experiences with 40 patients. J Thorac Cardiovasc Surg. 1971;62:529-541.
69. Sternik L, Moshkovitz Y, Hob H, Mohr R. Comparison of myocardial revascularization without cardiopulmonary bypass to standard open heart technique inpatient with left ventricular dysfunction. Eur J Cardiothorac Surg. 1997;11:123-128.
70. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. New Engl J Med. 1991;325:293-302.
71. Toda K, Mackenzie K, Mehra MR, et al. Revascularization in severe ventricular dysfunction (15 % < LVEF < 30 %): a comparison of bypass grafting and percutaneous intervention. Ann Thorac Surg. 2002;74:2082-2087.
72. Todurov B, Shevchenko V, Zelenchuk O, et al. The immediate results of coronary artery bypass grafting in patients with low ejection fraction of left ventricle. Polish J Cardiothoracic Surgery. 2011;8:24-25.
73. Thom T, Haase N, Rosamond W, et al. Heart Disease and Stroke Statistics -2006 Update. A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;85:151.
74. Tugtekin M, Gulielmos V, Cichon R, et al. Off-pump surgery for anterior vessels in patients with severe dysfunction of the left ventricle. Ann Thorac Surg. 2000;70:1034-1036.
75. Versteegha M, Lambb HJ, Baxc JJ, et al. MRI evaluation of left ventricular function in anterior LV aneurism before and after surgical resection. Ann Thorac Surg. 2003;75.
76. Wechsler AS, Junod FL. Coronary bypass grafting in patients with chronic congestive heart failure. Circulation. 1989;79(6):92-96.
77. Zacharias A, Schwann Т, Riordan C. et al.. Is hospital procedure volume a reliable marker of quality for CABG surgery? A comparison of risk and propensity adjusted operative and mid-term outcomes. Ann Thorac Surg. 2005;79:1961-1969.
78. Zubiate P, Kay JN, Dune EF. Myocardial revascularization for the patients with ejection fraction of 0.2 or less 12 years results. West J Med. 1984;140:745-749.
79. Yu СМ, Fung JW, Chan CK, et al. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure. J Cardiovasc Electrophysiol. 2004;15(9):1058-1065.

Echocardiographic assessment of mitral regurgitation

N.D. Oryshchyn

References

1. Agricola E, Oppizzi M, Pisani M, et al. Ischemic mitral regurgitation: mechanisms and echocardiographic classification. Eur J Echocardiogr. 2008;9:207-221.
2. Antonini-Canterin F, Beladan CC, Popescu BA. et al . Left atrial remodelling early after mitral valve repair for degenerative mitral regurgitation. Heart. 2008;94:759-764.
3. Caldarera I, Van Herwerden LA, Taams MA, et al. Multiplane transoesophageal echocardiography and morphology of regurgitant mitral valves in surgical repair. Eur Heart J. 1995;6:999-1006.
4. Chaliki H, Nishimura R, Enriquez-Sarano M, et al. A simplified, practical approach to assessment of severity of mitral regurgitation by Doppler color flow imaging with proximal convergence: validation with concomitant cardiac catheterization. Mayo Clin Proc. 1998;73:929-935.
5. Ciarka A, Braun J, et al. Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am J Cardiol. 2010;106(3):395-401.
6. Enriquez-Sarano M, Miller FJ, Hayes S, et al. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol. 1995;25:703-709.
7. Enriquez-Sarano M, Freeman WK, et al. Functional anatomy of mitral regurgitation: accuracy and outcome implications of transesophageal echocardiography. J Am Coll Cardiol.1999;34:1129-1136.
8. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. New Engl J. Med. 2005;352:875-883.
9. Grigioni F, Enriquez-Sarano M, Zehr KJ, et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759-1764.
10. Grossi EA, Crooke GA. Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization. Circulation. 2006;114(Suppl. 1):1573-1576.
11. Hall SA, Brickner E, Willett DL, et al. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta. Circulation. 1997;95:636-642.
12. Heinle SK, Hall SA, Brickner ME. Comparison of vena contracta width by multiplane transesophageal echocardiography with quantitative Doppler assessment of mitral regurgitation. Am J Cardiol. 1998;81:175-179.
13. Hung J, Papakostas L, Tahta SA, et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation. 2004;110 (Suppl. II):85-90.
14. Iung B, Baron G, Butchart EG, et al. Aprospective survey of patients with valvular heart disease in Europe: the EuroHeart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-1243.
15. Kongsaerepong V, Shiota M, Gillinov AM, et al. Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation. Am J Cardiol. 2006;98:504-508.
16. Kwan J, Shiota T, Agler DA, et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation. 2003;107:1135-1140.
17. Lancellotti P, Lebrun F, Pierard LA. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2003;42:1921-1928.
18. Lancellotti P, Pierard LA. Chronic ischaemic mitral regurgitation: Exercise testing reveals its dynamic component. Eur Heart J. 2005;26:1816-1817.
19. Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:307-332.
20. Lancellotti P, Marwick T, Pierard LA. How to manage ischaemic mitral regurgitation. Heart. 2008;94:1497-502.
21. Marciniak A, Claus P, Sutherland GR, et al. Changes in systolic left ventricular function in isolated mitral regurgitation. A strain rate imaging study. Eur Heart J. 2007;28:2627-2632.
22. Matsumura Y, Fukuda S, et al. Geometry of the proximal isovelocity surface area in mitral regurgitation by 3-dimensional color Doppler echocardiography: difference between functional mitral regurgitation and prolapse regurgitation. Am Heart J. 2008;155:231-238.
23. Messika-Zeitoun D, Bellamy M, Avierinos JF, et al. Left atrial remodelling in mitral regurgitation-methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study. Eur Heart J. 2007;28:1773-1781.
24. Monin JL, Dehant P, Roiron C, et al. Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes diagnostic accuracy and outcome implications. J Am Coll Cardiol. 2005;46:302-309.
25. O'Gara P, Sugeng L, Lang R. et al . The role of imaging in chronic degenerative mitral regurgitation.// JACC Cardiovasc Imaging. 2008;1:221-237
26. Sabbah HN, Rosman H, Kono T, et al. On the mechanism of functional mitral regurgitatio. Am J Cardiol. 1993;72:1074-1076.
27. Tibayan FA, Rodriguez F, Zasio MK, et al. Geometric distortions of the mitral valvular-ventricular complex in chronic ischemic mitral regurgitation. Circulation. 2003;108:116-121.
28. Tribouilloy C, Shen WF, Quéré JP, et al. Assessment of severity of mitral regurgitation by measuring regurgitant jet width at its origin with transesophageal Doppler color flow imaging. Circulation. 1992;85:1248-1253.
29. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-268.
30. Yosefy C, Hung J, Chua S, et al. Direct measurement of vena contracta area by real-time 3-dimensional echocardiography for assessing severity of mitral regurgitation. Am J Cardiol. 2009;104:978-983.
31. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777-802.

Early and late post-myocardial infarction left ventricular remodeling in patients after successful endovascular recanalization of infarction-related artery

L.M. Babii, N.P. Stroganova, Yu.O. Khomenko

References

1. Babii LM, Stroganova NP, Khomenko Yu.O. Left ventricular remodeling in patients with acute myocardial infarction under conservative and interventional treatment. Cardiac Surgery and Interventional Cardiology. 2014;3 (8):18-25. (in Russ.).
2. Babii LN, Stroganova NP, Savitskiy SYu, Ostapchuk UYu, Kisilevich LF, Khomenko YuO, Sledzevskaya IK. The relationship between exercise tolerance, functional state of left ventricle and blood aldosterone level in patients after myocardial infarction at prolonged follow-up. Ukrainian Cardiology Journal. 2014;2:48-54. (in Russ.).
3. Belenkov YuN. Left ventricular remodeling: an integrated approach. Russian Heart Failure Journal. 2004;4:161-164. (in Russ.).
4. Belov YuV, Varaksin VA. Post-infarction remodeling of the left ventricle of the heart. Moskva: De Njvj, 2002. 194 р. (in Russ.).
5. Coronary and heart failure. Ed. by R.S. Karpov. Tomsk: SST, 2005. 716 c. (in Russ.).
6. Nikitin NP, Alyavi AL, Goloskokova VYu. The features of the process of late cardiac remodeling in patients who underwent myocardial infarction. Kardiologiia. 1999;1:54-58. (in Russ.).
7. Ryabov VV, Sokolov AA, Ryabova TR, Markov VA. Structural and functional cardiac reconstruction. Tomsk: SST, 2010. 252 р. (in Russ.).
8. Ryabova TR, Ryabov VV. Remodeling of the left ventricle. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2001;4:65-69. (in Russ.).
9. Sledzevska ІК, Babii LN, Savitskiy SYu, Stroganova NP. The connection of intracardiac hemodynamics and the level of aldosterone in the blood of patients with myocardial infarction. Ukrainian Cardiology Journal. 2013;2:46-49. (in Ukr.).
10. Sokolov YuN, Sokolov MYu, Chubko VI. Long-term results of stenting in patients with chronic symptomatic occlusions. Ukrainian Cardiology Journal. 2011;5:30-36. (in Russ.).
11. Teterkina TV, Ryabov VV, Ryabova TR, Markov VA. Remodeling of the left ventricle. The Siberian Scientific Medical Journal. 2008;23(4):35-42. (in Russ.).
12. Shakhova E.B. Dynamics of echocardiographic parameters of left ventricular function in postinfarction patients. Radiologia-press. 2007;2:13-21. (in Russ.).
13. Cohn J.N, Ferrari R, Sharpe N. Cardiac remodeling concepts and clinical implication: consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J. Am. Coll. Cardiology. 2000;35:569-588.
14. Dalman J, Boerima E, Flater M. et al. Long-term safity and efficacy of percutaneous coronary intervention with stenting and coronary artery bаypass surgery for multivessel coronary artery disease: meta-analysis with 5-year patients -data from ARTSERACHI -II and SOS trial. Circulation. 2008;118:1146-1154.
15. Ferrarj R, Ctcjni G, Currello S. et al. Ischemic preconditioning, myocardial stenting and hibernation: basic aspects. Amer. Hеart J. 1999;136:61-68.
16. Kanel WB, Sorlie P, McMamare PM. Prognosis after initial myocardial infarction. Framingham study. Amer. J. Cardiology. 1979;44:53-59.
17. Pfeffer MA, Pfeffer JM. Ventricular enlargement and reduced survival after myocardial infarction. Circulation.1987;75 (Suppl. IV):93-97.
18. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. E[perimental observation and clinical implication. Circulation. 1990;81:1161-1172.
19. White HD, Norris RM, Brauin MA. еt al. Left ventricular end-systolic volume as the major determination of survival after myocardial infarction. Circulation. 1987;76:44-51.

Urgent off-pump coronary artery bypass grafting after thrombolysis in patient with acute coronary syndrome

V.I. Ursulenko, O.K. Gogayeva, L.V. Yakob, L.S. Dzakhoieva, Yu.S. Starodub

References

1. Kovalenko VN, Tseluyko VI, Goloborodko BI. Organization and standardization of treatment of acute coronary circulation disorders. Zdorovia Ukrainy. 2008;5:9-11. (in Russ.).
2. Kornatsky VM, Dorogiy AP, Manoylenko TS. et al. Cardiovascular Disease in Ukraine. Kyiv, 2012. 117 р. (in Ukr.).
3. Barbash GL. Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic (ASSENT 2) studies. JAMA. 2007;434:488-498.

Angioleiomyofibroma of the tricuspid valve: the case of diagnosis and surgical treatment

R.M. Vitovsky, V.P. Zakharova, O.A. Pishchurin, I.V. Martyshchenko, E.O. Bilynsky, V.V. Isaenko, O.Z. Paratsiy, О.S.Chumak, E.B. Ershova, О.V. Satmary

References

1. Abrikosov AI. Private pathological anatomy. Moskva: Medgiz, 1947. 574 p. (in Russ.).
2. Amano J, Nakayama J, Ikeda U. Epidemiology and frequency of cardiac tumors. Textbook of cardiac tumors. Tokyo: Nanzando, 2011:8-18.
3. Amano J, Nakayama J, Yoshimura Y, Ikeda U. Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences. Gen. Thorac. Cardiovasc. Surg. 2013;61(8):435-447.
4. Bruce CJ. Cardiac tumours: diagnosis and management. Heart. 2011;97(2):151-160.
5. Burke A, Loire R, Virmani R. Pericardial tumours. The international agency for research on cancer. Ch. 4. Tumours of the heart / Ed. by Travis W, Brambilla E, Muller-Hermelink HK, Harris CC. Lyon, France: IARC and WHO, 2004. 287 p.
6. Burke A, Virmani R. Tumors of the heart and great vessels. Atlas of tumor pathology. Washington DC: Armed Forces Institute of Pathology. 1996:1-11.
7. Feigin DS, Fenoglio JJ, McAllister HA, Madewell JE. Pericardial cysts. A radiologic-pathologic correlation and review. Radiology. 1977;125(1):15-20.
8. Gonzalez M, Krueger T, Schaefer SC. et al. Asymptomatic intrapericardial mature teratoma. Ann. Thorac. Surg. 2010;89(6):e46-e47.
9. Wold LE, Lie JT. Cardiac myxomas: a clinicopathologic profile. Am. J. Pathol. 1980;101(1):219-240.

First experience of 48 mm Xience Xpedition coronary stents implantation

S.М. Furkalo

References 

1. Hoffman R, Herrmann G, et al. Randomoszed comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowings. Amer. J. Cardiol. 2002;90:460-464.
2. Morgan K, Kapur A, Beatt K. Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention. Heart. 2004;90:732-738.
3. Raber L, Juni P, et al. Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. JACC. 2010;55 (12):1178-1188.

The case of successful revascularization of pathologically tortuous artery in patient with acute coronary syndrome

M.T. Vatutin, A.V. Dmitriev, V.B. Kostogryz, O.I. Stolika, Y.V. Yeshchenko, Y.P. Gritsenko, V.A. Karapysh

References

1. Belevitin AB, Khubulava GG, Vlasenko SV, et al. Features of the implementation of endovascular interventions in the presence of pathological tortuosity of the coronary bed. Abstracts of the All-Russian Congress of Cardiovascular Surgeons. 2007:123-124. (in Russ.).
2. Vatutin NT, Bakhteeva TD, Kalinkina NV, Peruyeva IA Congenital malformations of the coronary arteries. Serce i sudyny [Heart and vessels]. 2011;3:94-99. (in Russ.).
3. Lebedeva EO. Analysis of the prevalence of tortuosity of coronary arteries in patients with cardiovascular pathology. Sercevo-sudynna khirurgiya. 2012;20:302-306. (in Russ.).
4. Rudenko AV, Vatutin NT, Kalinkina NV, et al. The case of an abnormal retreat of the left coronary artery from the pulmonary artery trunk (Bland-White-Garland syndrome). Serce i sudyny [Heart and vessels]. 2011;4:112-116. (in Russ.).
5. Chumakova GA, Podkovyrkin VA. Clinical significance of pathological tortuosity of the coronary arteries. Heart. 2010;2(52):102-105. (in Russ.).
6. Stein PD, Hamid MS, Shivkumar K. et al. Effects of cyclic flexion of coronary arteries on progression of atherosclerosis. Am. J. Cardiol. 1994;73:431-437.
7. Zegers ES, Meursing BTJ, Zegers EB, Oude Ophuis A.J.M. Coronary tortuosity: a long and winding road. Neth. Heart J. 2007;15(5):191-195.

Successful repair of supravalvular aortic stenosis in patient with Williams – Beuren syndrome

B.M. Todurov

References 

1. Belozerov YuM. Pediatric cardiology. Moskva, 2004. (in Russ.).
2. Bondarenko IE. Surgical treatment of congenital aortic stenosis. Moskva, 2003. (in Russ.).
3. Collins RT, Kaplan P, Somes GW, Rome JJ. Long-term outcomes of patients with cardiovascular abnormalities and Williams syndrome. Am J Cardiol. 2010;105:874-878.
4. Deo SV, Burkhart HM, Schaff HV, et al. Late outcomes for surgical repair of supravalvar aortic stenosis. Ann Thorac Surg. 2012;94(3):854-859.
5. Kim YM, Yoo SJ, Choi JY, et al. Natural course of supravalvar aortic stenosis and peripheral pulmonary arterial stenosis in William's syndrome. Cardiol. Young. 1999;9:37-41.
6. Peterson TA, Todd DB, Edwards JE. Supravalvular aortic stenosis. J Thorac. Cardiovasc. Surg. 1965;50(5):734-741.
7. Piehler JM, Danielson GK, Pluth JR, et al. Enlargement of the aortic root or anulus with autogenous pericardial patch during aortic valve replacement. J Thorac Cardiovasc Surg. 1983;86:350-358.
8. Scott DJ, Campbell DN, Clarke DR, et al. Twenty-year surgical experience with congenital supravalvular aortic stenosis. Ann Thorac Surg. 2009;87:1501-1508.
9. Van Son JA, Danielson GK, Puga FJ, et al. Supravalvular aortic stenosis. Long-term results of surgical treatment. J Thorac Cardiovasc Surg. 1994;107:103-115.
10. Wren C, Oslizlok P, Bull C. Natural history of supravalvular aortic stenosis and pulmonary artery stenosis. J Am Coll Cardiol. 1990;15:1625-1630.

Almanac 2014: congenital heart disease

P.C. Kahr, G.-P. Diller 

References

1. Agnoletti G, Bordese R, Gabbarini F. Closure of a large ductus arteriosus in a preterm infant using the ADO II AS device. Heart. 2012;98:1394.
2. Agus MS, Asaro LA, Steil GM, et al. Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: a secondary analysis of the safe pediatric euglycemia after cardiac surgery trial. Circulation. 2014;129:2297-2304.
3. Alonso-Gonzalez R, Borgia F, Diller GP, et al. Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy, and association with survival. Circulation. 2013;127:882-890.
4. Assenza GE, Graham DA, Landzberg MJ, et al. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart. 2013;99:491-496.
5. Baba K, Kotani Y, Chetan D, et al. Hybrid versus Norwood strategies for single-ventricle palliation. Circulation. 2012;126 (Suppl. 1):S123-131.
6. Barst RJ, McGoon MD, Elliott CG, et al. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation. 2012;125:113-122.
7. Beaton A, Okello E, Lwabi P, et al. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation. 2012;125:3127-3132.
8. Bossers SS, Cibis M, Gijsen FJ, et al. Computational fluid dynamics in Fontan patients to evaluate power loss during simulated exercise. Heart. 2014;100:696-701.
9. Brickner ME. Cardiovascular management in pregnancy: congenital heart disease. Circulation. 2014;130:273-282.
10. Brown KL, Sullivan ID. Prenatal detection for major congenital heart disease: a key process measure for congenital heart networks. Heart. 2014;100:359-360.
11. Cantinotti M, Assanta N, Murzi B, et al. Controversies in the definition and management of insignificant left-to-right shunts. Heart. 2014;100:200-205.
12. Chetan D, Kotani Y, Jacques F, et al. Surgical palliation strategy does not affect interstage ventricular dysfunction or atrioventricular valve regurgitation in children with hypoplastic left heart syndrome and variants. Circulation. 2013;128 (Suppl. 1):S205-212.
13. Coats L, O’Connor S, Wren C, et al. The single-ventricle patient population: a current and future concern a population-based study in the North of England. Heart. 2014;100:1348-1353.
14. Cordina R, O’Meagher S, Gould H, et al. Skeletal muscle abnormalities and exercise capacity in adults with a Fontan circulation. Heart. 2013;99:1530-1534.
15. Cunnington C, Hampshaw SA, Mahadevan VS. Utility of real-time three-dimensional intracardiac echocardiography for patent foramen ovale closure. Heart. 2013;99:1789-1790.
16. Cuypers JA, Eindhoven JA, Slager MA, et al. The natural and unnatural history of the Mustard procedure: long-term outcome up to 40 years. Eur Heart J. 2014;35:1666-1674.
17. Cuypers JA, Witsenburg M, van der Linde D, et al. Pulmonary stenosis: update on diagnosis and therapeutic options. Heart. 2013;99:339-347.
18. D’Udekem Y, Xu M.Y, Galati JC, et al. Predictors of survival after single-ventricle palliation: the impact of right ventricular dominance. J Am Coll Cardiol. 2012;59:1178-1185.
19. Deal BJ, Jacobs ML. Management of the failing Fontan circulation. Heart. 2012;98:1098-1104.
20. Diller GP, Alonso-Gonzalez R, Kempny A, et al. B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy. Heart. 2012;98:736-742.
21. Diller GP, Kempny A, Liodakis E, et al. Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of Fallot. Circulation. 2012;125:2440-2446.
22. Douwes JM, Roofthooft MTR, Van Loon RLE, et al. Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre. Heart. 2014;100:224-230.
23. Duerr GD, Breuer J, Schiller W. A new transventricular aproach for pulmonary valve implantation in a patient with severe valve disease after tetralogy-of-Fallot repair. Heart. 2013;99:1469-1470.
24. Edwards NC, Griffiths M, Steeds RP. Intra-cardiac echocardiography in mitral valve repair: a novel use of a complimentary imaging modality in a difficult scenario. Heart. 2013;99:1791-1792.
25. Ferraz Cavalcanti PE, Sá MP, Santos CA, et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3118 patients from 48 studies. J Am Coll Cardiol. 2013;62:2227-2243.
26. Frigiola A, Hughes M, Turner M, et al. Physiological and phenotypic characteristics of late survivors of tetralogy of fallot repair who are free from pulmonary valve replacement. Circulation. 2013;128:1861-1868.
27. Frommelt PC, Guey LT, Minich LL, et al. Does initial shunt type for the Norwood procedure affect echocardiographic measures of cardiac size and function during infancy? The Single Ventricle Reconstruction trial. Circulation. 2012;125:2630-2638.
28. Frontera A, Thomas G, Duncan E. Cardiac arrest in concomitant Wolff-Parkinson-White syndrome and early repolarisation: is pathway ablation enough? Heart. 2014;100:598-599.
29. Gardiner HM, Kovacevic A, van der Heijden LB, et al. Prenatal screening for major congenital heart disease: assessing performance by combining national cardiac audit with maternity data. Heart. 2014;100:375-382.
30. Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot: the quest continues. Circulation. 2013;128:1855-1857.
31. Gopalamurugan AB, Reinthaler M, Mullen MJ. Percutaneous valve-in-valve implantations: importance of knowing the effective internal diameter of bioprosthetic valves. Heart. 2013;99:1709-1710.
32. Inuzuka R, Diller GP, Borgia F, et al. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012;125:250-259.
33. John AS, Johnson JA, Khan M, et al. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol. 2014;64:54-62.
34. Kampman MA, Balci A, van Veldhuisen DJ, et al. N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. Eur Heart J. 2014;35:708-715.
35. Kempny A, Dimopoulos K, Alonso-Gonzalez R, et al. Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndrome. Int J Cardiol. 2013;168:4784-4789.
36. Kempny A, Dimopoulos K, Gatzoulis MA. Single-ventricle physiology in the UK: an ongoing challenge of growing numbers and of growing complexity of congenital heart disease. Heart. 2014;100:1315-1316.
37. Kempny A, Dimopoulos K, Uebing A, et al. Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life - single centre experience and review of published data. Eur Heart J. 2012;33:1386-1396.
38. Khairy P, Clair M, Fernandes SM, et al. Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation. 2013;127:331-339.
39. Khoshnood B, Lelong N, Houyel L, et al. Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study. Heart. 2012;98:1667-1673.
40. Kim JB, Yoo DG, Kim GS, et al. Mild-to-moderate functional tricuspid regurgitation in patients undergoing valve replacement for rheumatic mitral disease: the influence of tricuspid valve repair on clinical and echocardiographic outcomes. Heart. 2012;98:24-30.
41. Krieger EV, Stout K. Progress: the ROPAC multinational registry advances our understanding of an important outcome in pregnant women with heart disease. Heart. 2014;100:188-189.
42. Lauten A, Hoyme M, Figulla HR. Severe pulmonary regurgitation after tetralogy-of-Fallot repair: transcatheter treatment with the Edwards SAPIEN XT heart valve. Heart. 2012;98:623-624.
43. Lee SP, Kim HK, Kim KH, et al. Prevalence of significant tricuspid regurgitation in patients with successful percutaneous mitral valvuloplasty for mitral stenosis: results from 12 years’ follow-up of one centre prospective registry. Heart. 2013;99:91-97.
44. Lloyd DF, Cutler L, Tibby SM, et al. Analysis of preoperative condition and interstage mortality in Norwood and hybrid procedures for hypoplastic left heart syndrome using the Aristotle scoring system. Heart. 2014;100:775-780.
45. Lutaaya M, Rajagopal R, More RS. Giant unruptured Sinus of Valsalva aneurysm: an unusual cause of aortic regurgitation. Heart. 2013;99:972.
46. Marelli AJ, Ionescu-Ittu R, Mackie AS, et al. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130:749-756.
47. McCrossan B, Morgan G, Grant B, et al. A randomised trial of a remote home support programme for infants with major congenital heart disease. Heart. 2012;98:1523-1528.
48. Miranda J.O, Callaghan N, Miller O, et al. Right aortic arch diagnosed antenatally: associations and outcome in 98 fetuses. Heart. 2014;100:54-59.
49. Moceri P, Dimopoulos K, Liodakis E, et al. Echocardiographic predictors of outcome in eisenmenger syndrome. Circulation. 2012;126:1461-1468.
50. Mocumbi AO, Falase AO. Recent advances in the epidemiology, diagnosis and treatment of endomyocardial fibrosis in Africa. Heart. 2013;99:1481-1487.
51. Mocumbi AO, Sliwa K. Women’s cardiovascular health in Africa. Heart. 2012;98:450-455.
52. Mokhles MM, Charitos EI, Stierle U, et al. The fate of pulmonary conduits after the Ross procedure: longitudinal analysis of the German-Dutch Ross registry experience. Heart. 2013;99:1857-1866.
53. Mongeon FP, Gurvitz MZ, Broberg CS, et al. Aortic root dilatation in adults with surgically repaired tetralogy of fallot: a multicenter cross-sectional study. Circulation. 2013;127:172-179.
54. Morrison ML, Sands AJ, McCusker CG, et al. Exercise training improves activity in adolescents with congenital heart disease. Heart. 2013;99:1122-1128.
55. Newburger J.W, Sleeper L.A, Frommelt P.C, et al. Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial. Circulation. 2014;129:2013-2020.
56. O’Meagher S, Munoz PA, Alison JA, et al. Exercise capacity and stroke volume are preserved late after tetralogy repair, despite severe right ventricular dilatation. Heart. 2012;98:1595-1599.
57. Opotowsky AR, Siddiqi OK, D’Souza B, et al. Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart. 2012;98:145-151.
58. Orwat S, Diller GP. Risk stratification in adults with repaired Tetralogy of Fallot: the long journey from clinical parameters and surface ECG to in-depth assessment of myocardial mechanics, volume and pressure loading. Heart. 2014;100:185-187.
59. Pagel C, Crowe S, Brown K, et al. The benefits and risks of risk-adjustment in paediatric cardiac surgery. Heart. 2014;100:528-529.
60. Pagel C, Utley M, Crowe S, et al. Real time monitoring of risk-adjusted paediatric cardiac surgery outcomes using variable life-adjusted display: implementation in three UK centres. Heart. 2013;99:1445-1450.
61. Pieper PG, Balci A, Aarnoudse JG, et al. Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease. Circulation. 2013;128:2478-2487.
62. Radke RM, Diller GP, Duck M, et al. Endothelial function in contemporary patients with repaired coarctation of aorta. Heart. 2014;100:1696-1701.
63. Remenyi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease — an evidence-based guideline. Nat Rev Cardiol. 2012;9:297-309.
64. Rider OJ, Bissell M, Myerson SG. Congenital aortopulmonary window;an unusual cause of breathlessness. Heart. 2013;99:1546.
65. Roberts K, Maguire G, Brown A, et al. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children. Circulation. 2014;129:1953-1961.
66. Rogers LS, Glatz AC, Ravishankar C, et al. 18 years of the Fontan operation at a single institution: results from 771 consecutive patients. J Am Coll Cardiol. 2012;60:1018-1025.
67. Roifman I, Therrien J, Ionescu-Ittu R, et al. Coarctation of the aorta and coronary artery disease: fact or fiction? Circulation. 2012;126:16-21.
68. Roos-Hesselink JW, Ruys TPE, Stein JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34:657-665.
69. Ruys TP, Roos-Hesselink JW, Hall R, et al. Heart failure in pregnant women with cardiac disease: data from the ROPAC. Heart. 2014;100:231-238.
70. Schranz D. Hybrid approach in hypoplastic left heart syndrome. Heart. 2014;100:750-751.
71. Shafer KM, Garcia JA, Babb TG, et al. The importance of the muscle and ventilatory blood pumps during exercise in patients without a subpulmonary ventricle (Fontan operation). J Am Coll Cardiol. 2012;60:2115-2121.
72. Shahian DM, Jacobs JP, Edwards FH, et al. The society of thoracic surgeons national database. Heart. 2013;99:1494-1501.
73. Siddiqui J, Brizard CP, Galati JC, et al. Surgical valvotomy and repair for neonatal and infant congenital aortic stenosis achieves better results than interventional catheterization. J Am Coll Cardiol. 2013;62:2134-2140.
74. Swartz MF, Sena A, Atallah-Yunes N, et al. Decreased incidence of supravalvar pulmonary stenosis after arterial switch operation. Circulation. 2012;126 (Suppl. 1):S118-122.
75. Tutarel O, Kempny A, Alonso-Gonzalez R, et al. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J. 2014;35:725-732.
76. Ubeda Tikkanen A, Opotowsky AR, Bhatt AB, et al. Physical activity is associated with improved aerobic exercise capacity over time in adults with congenital heart disease. Int J Cardiol. 2013;168:4685-4691.
77. Valente AM, Gauvreau K, Assenza GE, et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014;100:247-253.
78. Van der Bom T, Bouma BJ, Meijboom FJ, et al. The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation. Am Heart J. 2012;164:568-575.
79. Van der Bom T, Winter MM, Bouma BJ, et al. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation. 2013;127:322-330.
80. Van der Bom T, Winter MM, Groenink M, et al. Right ventricular end-diastolic volume combined with peak systolic blood pressure during exercise identifies patients at risk for complications in adults with a systemic right ventricle. J Am Coll Cardiol. 2013;62:926-936.
81. Vettukattil JJ. Three dimensional echocardiography in congenital heart disease. Heart. 2012;98:79-88.
82. Westhoff-Bleck M, Schieffer B, Tegtbur U, et al. Aerobic training in adults after atrial switch procedure for transposition of the great arteries improves exercise capacity without impairing systemic right ventricular function. Int J Cardiol. 2013;170:24-29.
83. Wray J, Frigiola A, Bull C. Loss to specialist follow-up in congenital heart disease, out of sight, out of mind. Heart. 2013;99:485-490.
84. Wren C, O’Sullivan J. Loss to follow-up of adults with repaired congenital heart disease. Heart. 2013;99:440-441.
85. Yang J, Yang L, Yu S, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol. 2014;63:1159-1168.
86. Zhao QM, Ma XJ, Ge XL, et al. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet. 2014;384:747-754.
87. Zijlstra WM, Douwes JM, Rosenzweig EB, et al. Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies. J Am Coll Cardiol. 2014;63:2159-2169.
88. Zomer AC, Ionescu-Ittu R, Vaartjes I, et al. Sex differences in hospital mortality in adults with congenital heart disease: the impact of reproductive health. J Am Coll Cardiol. 2013;62:58-67.
89. Zomer AC, Vaartjes I, van der Velde ET, et al. Heart failure admissions in adults with congenital heart disease, risk factors and prognosis. Int J Cardiol. 2013;168:2487-2493.
90. Zuhlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities. Heart. 2013;99:1554-1561.